Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sevelamer and CCK on GLP-1 in Type 2 Diabetes
NCT02445508Completed
- Sponsor
- Gentofte Hospital
- Start
- May 2015
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial of sevelamer carbonate in type 2 diabetes mellitus (T2DM), sponsored by Gentofte Hospital. Started May 2015; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02445508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445508.